TY - JOUR
T1 - Disruption of the structural maintenance of chromosomes 5/6 complex enables tumor mutagenesis
AU - Tran, Thi
AU - Fan, Jiayi
AU - Zhao, Xiaolan
AU - Green, Abby M.
N1 - Publisher Copyright:
© The Author(s) 2026. Published by Oxford University Press. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
PY - 2026/6
Y1 - 2026/6
N2 - The structural maintenance of chromosomes (SMC) 5/6 complex is conserved and essential for mammalian development. SMC5/6 germline variants in cells, model organisms, and patients results in genome instability. However, the consequences of somatic SMC5/6 dysfunction in cancer are unknown. We report a pan-cancer analysis of SMC5/6 variants across three databases in which thousands of tumors across all tissue types harbored copy number alteration (CNA) and/or small variants in SMC5/6 genes. We found that deleterious variants—those predicted to cause protein disruption, but not CNAs, in SMC5/6 genes were associated with elevated tumor mutational burden (TMB). Mutagenesis in tumors with deleterious SMC5/6 variants was largely due to polymerase epsilon dysfunction and mismatch repair deficiency. Patients with SMC5/6 gene variants in tumors exhibited improved survival, in part due to a superior response to immunotherapy. Our findings demonstrate that SMC5/6 complex disruption in cancer predicts elevated TMB and susceptibility to immunotherapy, indicating the potential to use SMC5/6 gene status for prognostic implications and tailored therapeutic approaches.
AB - The structural maintenance of chromosomes (SMC) 5/6 complex is conserved and essential for mammalian development. SMC5/6 germline variants in cells, model organisms, and patients results in genome instability. However, the consequences of somatic SMC5/6 dysfunction in cancer are unknown. We report a pan-cancer analysis of SMC5/6 variants across three databases in which thousands of tumors across all tissue types harbored copy number alteration (CNA) and/or small variants in SMC5/6 genes. We found that deleterious variants—those predicted to cause protein disruption, but not CNAs, in SMC5/6 genes were associated with elevated tumor mutational burden (TMB). Mutagenesis in tumors with deleterious SMC5/6 variants was largely due to polymerase epsilon dysfunction and mismatch repair deficiency. Patients with SMC5/6 gene variants in tumors exhibited improved survival, in part due to a superior response to immunotherapy. Our findings demonstrate that SMC5/6 complex disruption in cancer predicts elevated TMB and susceptibility to immunotherapy, indicating the potential to use SMC5/6 gene status for prognostic implications and tailored therapeutic approaches.
UR - https://www.scopus.com/pages/publications/105041053724
U2 - 10.1093/narcan/zcag012
DO - 10.1093/narcan/zcag012
M3 - Article
C2 - 42181931
AN - SCOPUS:105041053724
SN - 2632-8674
VL - 8
JO - NAR Cancer
JF - NAR Cancer
IS - 2
ER -